DSKYF - Pfizer faces setback in Enhertu patent dispute with Daiichi
2024-01-17 07:08:09 ET
More on Pfizer
- Pfizer Is Part Of The 2024 Healthcare Sector Rally Cohort
- Pfizer Inc. (PFE) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
- Pfizer: 50% Down From The Highs, Generous Dividend, And Robust Balance Sheet
- First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
- Rebranded Investor Movement Index gains in December, still ‘moderately low’
For further details see:
Pfizer faces setback in Enhertu patent dispute with Daiichi